Catalyst Pharmaceuticals (CPRX) FCF Margin (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,047.00 |
| Dec 31, 2025 | 753.00 |
| Sep 30, 2025 | -2,677.00 |
| Jun 30, 2025 | 617.00 |
| Mar 31, 2025 | -746.00 |
| Dec 31, 2024 | -651.00 |
| Sep 30, 2024 | 416.00 |
| Jun 30, 2024 | 2,005.00 |
| Mar 31, 2024 | -1,804.00 |
| Dec 31, 2023 | 636.00 |
| Sep 30, 2023 | 1,300.00 |
| Jun 30, 2023 | 1,683.00 |
| Mar 31, 2023 | -5,191.00 |
| Dec 31, 2022 | -619.00 |
| Sep 30, 2022 | 2,284.00 |
| Jun 30, 2022 | 2,964.00 |
| Mar 31, 2022 | -3,027.00 |
| Dec 31, 2021 | -1,024.00 |
| Sep 30, 2021 | 1,708.00 |
| Jun 30, 2021 | 3,349.00 |
| Mar 31, 2021 | -3,264.00 |
| Dec 31, 2020 | 319.00 |
| Sep 30, 2020 | -575.00 |
| Jun 30, 2020 | 2,005.00 |
| Mar 31, 2020 | -1,605.00 |
| Dec 31, 2019 | -1,183.00 |
| Sep 30, 2019 | 388.00 |
| Jun 30, 2019 | 11,320.00 |
| Mar 31, 2019 | 161,724.00 |